Answers are grounded in this paper and cite their sources.
As the incidence and prevalence of HIV infection in women continue to rise, it is important to consider gender-specific issues when reviewing antiretroviral therapy options for women. Several studies report higher plasma concentrations as well as higher rates of adverse events in women for certain antiretroviral agents as compared with men. Ancestral history as it relates to pharmacogenomics has also been shown to impact drug metabolism and hypersensitivity reactions. Contraindicated drugs in pregnancy and changes in antiretroviral concentrations intrapartum, as well as interactions with oral contraceptive pills are also important issues to consider. The potential effects of gynecological and hormonal issues need to be considered in the treatment plan. Finally, social issues including mental health issues, caring for children, illicit drug use and history of abuse are also important factors as they can affect antiretroviral drug adherence in women.
No takes yet. Share an insight, caveat, or question.
Jaworsky et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: